{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:05:36Z","timestamp":1790697936595,"version":"4.1.0"},"reference-count":25,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    <jats:bold>Purpose:<\/jats:bold>\n                    To assess whether topical low-dose 0.01% atropine eye drops effectively alleviate floater symptoms, as measured by scores from a modified National Eye Institute Visual Function Questionnaire.\n                    <jats:bold>Methods:<\/jats:bold>\n                    This is a retrospective case series conducted at the Retina Group of Washington. Adults with persistently symptomatic vitreous floaters and either vitreous syneresis without posterior vitreous detachment (PVD) or a history of PVD for at least 3 months were included. Subjects with significant vitreoretinal pathology, significant media opacity, anatomic narrow angles, or a history of pars plana vitrectomy (PPV) were excluded. Patients completed a modified National Eye Institute Visual Function Questionnaire before using topical low-dose 0.01% atropine eye drops once daily for 1 week. The same questionnaire was then completed after the 1-week period to assess treatment response. The primary outcome measure was satisfaction with the drops.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 44 patients received 0.01% atropine eye drops prescribed for daily application in either 1 or both eyes. There were 22 patients who completed at least 7 days of consecutive drop use. Of these, 13 patients (59.1%) were \u201csatisfied\u201d or \u201cvery satisfied\u201d with the drops, and 11 patients (50%) reported that they would continue using the medication.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Low-dose 0.01% atropine eye drops may be an effective, noninvasive treatment option for select patients with persistently symptomatic vitreous floaters resulting from vitreous syneresis or PVD.\n                  <\/jats:p>","DOI":"10.1177\/24741264251364819","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:06:05Z","timestamp":1755691565000},"page":"831-835","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-Dose 0.01% Atropine Eye Drops for Symptomatic Vitreous Floaters: A Noninvasive, Safe, and Effective Therapeutic Option"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-5660","authenticated-orcid":false,"given":"Jeanette","family":"Du","sequence":"first","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabbagh","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Do","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Huang","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Levinson","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamud","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8177-8715","authenticated-orcid":false,"given":"Mohammed K.","family":"Barazi","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-2341","authenticated-orcid":false,"given":"Mohsin H.","family":"Ali","sequence":"additional","affiliation":[{"name":"Retina Group of Washington, Reston, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.11.008"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02160337"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0256-x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2013.03.27"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15414"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2009.00638.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000456"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.05.020"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000065"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.01.026"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-4112-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/bem.22386"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000063"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01261-w"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700026"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.2388"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-2205-3"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.07.004"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.1091"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.3820"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2320"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.624472"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15761"},{"key":"e_1_3_2_26_2","first-page":"4237","article-title":"Vitreous floaters functional questionnaire for vision degrading Myodesopsia","volume":"64","author":"Nguyen J","year":"2023","unstructured":"Nguyen J, Boneva SK, Nguyen-Cuu J, et al Vitreous floaters functional questionnaire for vision degrading Myodesopsia. Invest Ophthalmol Vis Sci. 2023;64:4237.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264251364819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264251364819","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264251364819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:24:17Z","timestamp":1790695457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264251364819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/24741264251364819"],"URL":"https:\/\/doi.org\/10.1177\/24741264251364819","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}